MERCER; Stephen E.
Patent Applications and Registrations
Patent applications and USPTO patent grants for MERCER; Stephen E..The latest application filed is for "angptl2 antisense oligonucleotides and uses thereof".
- MERCER; Stephen E. - Wakefield MA
- Mercer; Stephen E. - Wallingford CT
- MERCER; Stephen E. - Middletown CT
- Mercer; Stephen E. - Middleton CT
- Mercer; Stephen E - Greenville DE
- Mercer, Stephen E. - Greenville DE
| Patent | Date |
|---|---|
| Angptl2 Antisense Oligonucleotides And Uses Thereof App 20220213484 - ANDERSON; Brian R. ; et al. | 2022-07-07 |
| Tau Antisense Oligomers And Uses Thereof App 20220143064 - Olson; Richard E. ; et al. | 2022-05-12 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20210378652 - OLSON; Richard E. ; et al. | 2021-12-09 |
| Naphthyridinone Compounds Useful As T Cell Activators App 20210277004 - Chupak; Louis S. ; et al. | 2021-09-09 |
| Tau antisense oligomers and uses thereof Grant 11,077,132 - Olson , et al. August 3, 2 | 2021-08-03 |
| CAMK2D antisense oligonucleotides and uses thereof Grant 11,058,767 - Olson , et al. July 13, 2 | 2021-07-13 |
| Tau antisense oligomers and uses thereof Grant 10,799,523 - Olson , et al. October 13, 2 | 2020-10-13 |
| Methods of Selecting Therapeutic Molecules App 20190383797 - OLSON; Richard E. ; et al. | 2019-12-19 |
| Camk2d Antisense Oligonucleotides And Uses Thereof App 20190275148 - Olson; Richard E. ; et al. | 2019-09-12 |
| Tau Antisense Oligomers And Uses Thereof App 20180161356 - Olson; Richard E. ; et al. | 2018-06-14 |
| Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid production Grant 9,833,454 - Boy , et al. December 5, 2 | 2017-12-05 |
| Difluoromethoxy Compound With Low Bioactivation Potential For The Reduction Of Beta-amyloid Production App 20170182050 - Boy; Kenneth M. ; et al. | 2017-06-29 |
| Tau Antisense Oligomers and Uses Thereof App 20160237427 - OLSON; Richard E. ; et al. | 2016-08-18 |
| Therapeutic agents for the treatment of migraine Grant 7,772,244 - Degnan , et al. August 10, 2 | 2010-08-10 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,544,680 - Chaturvedula , et al. June 9, 2 | 2009-06-09 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,470,680 - Chaturvedula , et al. December 30, 2 | 2008-12-30 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,470,679 - Mercer , et al. December 30, 2 | 2008-12-30 |
| Constrained Compounds as CGRP-Receptor Antagonists App 20080287422 - Chaturvedula; Prasad V. ; et al. | 2008-11-20 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,384,931 - Chaturvedula , et al. June 10, 2 | 2008-06-10 |
| Constrained compounds as CGRP-receptor antagonists Grant 7,384,930 - Chaturvedula , et al. June 10, 2 | 2008-06-10 |
| Constrained Compounds As Cgrp-receptor Antagonists App 20070259850 - Mercer; Stephen E. ; et al. | 2007-11-08 |
| Constrained Compounds As Cgrp-receptor Antagonists App 20070259851 - Chaturvedula; Prasad V. ; et al. | 2007-11-08 |
| Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme Grant 7,125,870 - Xue , et al. October 24, 2 | 2006-10-24 |
| Constrained compounds as CGRP-receptor antagonists App 20060229447 - Chaturvedula; Prasad V. ; et al. | 2006-10-12 |
| Constrained compounds as CGRP-receptor antagonists App 20060094707 - Chaturvedula; Prasad V. ; et al. | 2006-05-04 |
| Novel therapeutic agents for the treatment of migraine App 20050215576 - Degnan, Andrew P. ; et al. | 2005-09-29 |
| Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme App 20040122005 - Xue, Chu-Biao ; et al. | 2004-06-24 |
| Lactam metalloprotease inhibitors Grant 6,620,823 - Maduskuie , et al. September 16, 2 | 2003-09-16 |
| Novel lactam metalloprotease inhibitors App 20020042398 - Maduskuie, Thomas P. ; et al. | 2002-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 